Pharmacokinetic profiles of florfenicol in spotted halibut, Verasper variegatus, at two water temperatures.

Abstract

The pharmacokinetic profiles of florfenicol in the spotted halibut (Verasper variegatus) were investigated at 15 and 20°C water temperatures, respectively. Florfenicol content in plasma samples was analyzed using an HPLC method. Drug concentration versus time data were best fitted to a three-compartment model after a single intravenous administration (15mg/kg BW), and fitted to a two-compartment model after an oral administration (30mg/kg BW) at 15 and 20°C. The florfenicol concentration in the blood increased slowly during the 12hr following an oral administration at 15°C, with a peak concentration (Cmax ) of 9.1mg/L, and then declined gradually. The half-lives of absorption, distribution, and elimination phase were 2.18, 5.66 and 14.25hr, respectively. The bioavailability (F) was calculated to be 24.14%. After an oral administration at 20°C, shorter half-lives of absorption (1.33hr), distribution (2.51hr) and elimination (9.71hr), a higher Cmax (12.2mg/L), and a similar F (23.98%) were found. Based on the pharmacokinetics and pharmacodynamics, an oral dose of 30mg/kg BW was suggested to be efficacious for bacterial disease control in spotted halibut farming.